Mark C. McKenna insider trades
Open-market stock purchases and sales by Mark C. McKenna, Unknown at Apogee Therapeutics, Inc, from SEC Form 4 filings since Jan 8, 2019.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +173%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc | Sold (not open market) | — |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc | Sold (not open market) | $3.5M |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc | Sold (not open market) | $455K |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc | Sold (not open market) | $602K |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc | Sold (not open market) | $651K |
| Jul 20, 2026 | FRNM Freenome, Inc | Bought (not open market) | — |
| Jun 9, 2026 | APGE Apogee Therapeutics, Inc | Bought (not open market) | — |
| May 27, 2026 | SYRE Spyre Therapeutics, Inc | Bought (not open market) | — |
| Jan 7, 2026 | NAMS NewAmsterdam Pharma Co NV | Bought (not open market) | — |
| Jan 7, 2026 | NAMS NewAmsterdam Pharma Co NV | Bought (not open market) | — |
Companies traded
- APGE Apogee Therapeutics, Inc: 2 buys, last Sep 3, 2026
- FRNM Freenome, Inc: other filings, last Jul 20, 2026
- SYRE Spyre Therapeutics, Inc: other filings, last May 27, 2026
- NAMS NewAmsterdam Pharma Co NV: other filings, last Jan 7, 2026
- BBOT BridgeBio Oncology Therapeutics, Inc: other filings, last Aug 11, 2025
- RXDX Prometheus Biosciences, Inc: 7 sales, last Jun 16, 2023
- BHC Bausch Health Companies Inc: 1 sale, last Aug 19, 2019